We talk to Cesar – COO of MedicScen, who is about to revolutionize the treatment of diabetes patients.

Diabetes patients have to live with many drawbacks in their life, including (but not limited to):
1) They have to stab themselves daily to measure their blood sugar
2) They have to inject themselves with insulin – for some on a daily basis.

And MedicSen wants to change both. MedicSen is in the current batch of the Merck Accelerator Program. Tune in to learn more!

Learn more here: https://accelerator.merckgroup.com/

About our sponsor:

The Accelerator program in Darmstadt, Germany

The Merck Accelerator program in Darmstadt, Germany supports early-stage companies that are focused on the fields of healthcare, life science, performance materials, and additional search fields, such as bio-interfaces and sensors, enablers of precision farming, 3D printing, future organic chemistry, microbiome research, and smart site management. The program focuses primarily on digital business models. Selected companies will receive office space at the new Merck Innovation Center in Darmstadt, as well as mentoring and in-depth coaching from a network comprising over 50,000 experts from 67 countries. Additionally, they will receive financial support of up to € 50,000. Oculyze, Living Brain, and MedicSen are three of the seven current participants of the program.

Learn more here: https://accelerator.merckgroup.com/

Twitter ► https://twitter.com/startuprad_io
Facebook ► https://www.facebook.com/startupradioGermany/
Meetup ► https://www.meetup.com/de-DE/Startup-Couch-TV-Talks/

Subscribe to our podcasts on iTunes:


Subscribe in other ways: www.startupradio.fm

Our websites: